E-Selectin was associated with higher T2D risk in the meta-analysis (HRper SD: 1.34 (95% CI: 1.16, 1.54); I2 = 63%; n = 9 studies) (Figure 2). The gene discussed is SELE; the disease is type 2 diabetes mellitus.